DYN vs LEN · $1.19B cap vs rev $34.19B
Dyne Therapeutics Inc (DYN) versus LEN (LEN) — a side-by-side from cached financials, not a winner call.
Dyne Therapeutics Inc (DYN) is a biotechnology company listed on US.
LEN (LEN) common stock.
DYN does not have a complete income-statement cache yet.
Latest reported LEN revenue for 2025-11-30 was $34.19B. Net income was $2.08B. Revenue was down 3.5% from 2024-11-30 to 2025-11-30. LEN currently screens at market cap $0.
DYN currently screens at market cap $1.19B. LEN currently screens at market cap $0.
Not investment advice. Open the DYN and LEN stock pages for the full models.
Not investment advice.